Ongoing Research: Additional Phase II and Phase III trials are evaluating vitamin C injections as adjuvant therapy for several malignancies
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial." The Lancet , 402(10404), 529-544
Each of these conditions presents unique challenges and can vary significantly in terms of symptoms and severity, making it essential for patients to receive tailored care and management strategies
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
GNova provides services like PCD franchise, contract manufacturing, and customer support